Examine the mechanism of drug scheduling (Schedule H1, Schedule K) under Indian pharmaceutical law and its role in balancing accessibility and misuse prevention.

Q. Examine the mechanism of drug scheduling (Schedule H1, Schedule K) under Indian pharmaceutical law and its role in balancing accessibility and misuse prevention. (15 marks, 250 words)

Drug scheduling under the Drugs Rules, 1945, framed under the Drugs and Cosmetics Act, 1940, sorts medicines into regulatory tiers by their risk profile — calibrating how freely a drug may be sold against its potential for harm. Recent tightening of high-alcohol formulations illustrates this balancing act.

Mechanism of scheduling - Schedule K grants exemptions from licensing and other provisions for low-risk classes — e.g. tinctures of cardamom and ginger — easing household and rural access [1]. - Schedule H1 is the restrictive tier: prescription-only sale by a Registered Medical Practitioner, with mandatory record-keeping to trace habit-forming and misuse-prone drugs [1]. - Reclassification between tiers is done by executive rule-making (Schedule amendment) rather than fresh law, allowing agile response to emerging misuse.

Balancing accessibility and misuse prevention - Accessibility: Schedule K keeps benign remedies cheap and licence-free, supporting last-mile healthcare in villages [2]. - Misuse prevention: some exempted tinctures carried 80–90% v/v alcohol, enabling intoxication; the July 2026 amendment moved formulations above 12% v/v and 30 mL from Schedule K to Schedule H1 [1]. - Trade-off: withdrawing the village cough-syrup exemption (Dec 2025) curbs abuse but risks access gaps, demanding careful drawing of thresholds [2].

Scheduling thus operates as a graduated dial, not a binary switch — expanding access for safe drugs while ring-fencing risky ones behind prescription control. A responsive, evidence-based scheduling regime, backed by CDSCO–state coordination, best reconciles public health protection with equitable medicine access.

(~250 words)

Sources: 1. Government amends Drugs Rules, 1945 to Strengthen Regulation of High Alcohol-Containing Drug Formulations, PIB (Jul 2026) — Schedule K exemption, shift to Schedule H1, 12% v/v/30 mL threshold, 80–90% v/v tinctures, prescription/record-keeping rule 2. Union Health Ministry Amends Drugs Rules, 1945; Exemption for Sale of Cough Syrups in Small Villages Withdrawn, PIB (Dec 2025) — withdrawal of Schedule K cough-syrup exemption, access-vs-misuse trade-off